BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Criss CR, Makary MS. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(3): 413-424 [PMID: 36688022 DOI: 10.3748/wjg.v29.i3.413]
URL: https://www.wjgnet.com/1948-5182/full/v29/i3/413.htm
Number Citing Articles
1
Kelly Hao, Andrew J Paik, Lauren H Han, Mina S Makary. Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinomaWorld Journal of Radiology 2024; 16(10): 512-527 doi: 10.4329/wjr.v16.i10.512
2
Jingxin Yan, Yonghao Wen, Manjun Deng, Bin Ye, Xinlian Liu, Lushun Zhang. Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic ReviewsJournal of Hepatocellular Carcinoma 2023; : 1723 doi: 10.2147/JHC.S429352
3
Elliott L. Fite, Mina S. Makary. Transarterial Chemoembolization Treatment Paradigms for Hepatocellular CarcinomaCancers 2024; 16(13): 2430 doi: 10.3390/cancers16132430
4
Cody R. Criss, Mina S. Makary. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver TumorsBiology 2023; 12(7): 999 doi: 10.3390/biology12070999
5
Andrei M. Jipa, Mina S. Makary. Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel ApplicationsCancers 2024; 16(7): 1271 doi: 10.3390/cancers16071271
6
Yu-Bo Zhang, Gang Yang, Yang Bu, Peng Lei, Wei Zhang, Dan-Yang Zhang. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinomaWorld Journal of Gastroenterology 2023; 29(43): 5804-5817 doi: 10.3748/wjg.v29.i43.5804
7
Jie Lu, Lili Shi, Caiming Zhang, Fabiao Zhang, Miaoguo Cai. Prognostic significance of pyrimidine metabolism-related genes as risk biomarkers in hepatocellular carcinomaJournal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2385266